Hydrolysis of pyridoxal-5'-phosphate in plasma in conditions with raised alkaline phosphate.
Open Access
- 1 March 1980
- Vol. 21 (3), 192-194
- https://doi.org/10.1136/gut.21.3.192
Abstract
Hydrolysis of pyridoxal phosphate in plasma was demonstrated in patients with liver disease and other conditions with raised alkaline phosphatase, and this usually closely paralleled the alkaline phosphatase level, whether of liver or bone origin. The endogenous plasma pyridoxal phosphate was inversely related to the alkaline phosphatase, and plasma hydrolysis of pyridoxal phosphate may at least in part be responsible. Very large doses of vitamin B6 may be necessary to compensate for this hydrolysis.This publication has 12 references indexed in Scilit:
- Vitamin B6 deficiency in chronic liver disease--evidence for increased degradation of pyridoxal-5'-phosphate.Gut, 1977
- Abnormal Regulation of Plasma Pyridoxal 5'-Phosphate in Patients with Liver DiseaseGastroenterology, 1976
- Effect of riboflavin on red-cell metabolism of vitamin B6Nature, 1976
- Pyridoxal 5'-phosphate in plasma: source, protein-binding, and cellular transport.1974
- Plasma binding of vitamin B6 compoundsNature, 1974
- Conversion of vitamin B6 compounds to active forms in the red blood cellJCI Insight, 1971
- The measurement of serum pyridoxal by a microbiological assay using Lactobacillus caseiJournal of Clinical Pathology, 1970
- Vitamins and Liver InjuryThe American Journal of Clinical Nutrition, 1970
- The Specific Binding of Pyridoxal 5'-Phosphate to Bovine Plasma AlbuminJournal of Biological Chemistry, 1962
- Pyridoxal phosphate breakdown by an alkaline-phosphatase preparationBiochemical Journal, 1961